CVE-2021-1130: Cisco DNA Center Cross-Site Scripting Vulnerability
A vulnerability in the web-based management interface of Cisco DNA Center software could allow an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack against a user of the interface of an affected device. The vulnerability exists because the web-based management interface does not properly validate user-supplied input. An attacker could exploit this vulnerability by persuading a user to click a crafted link. A successful exploit could allow the attacker to execute arbitrary script code in the context of the interface or access sensitive, browser-based information. To exploit this vulnerability, an attacker would need to have administrative credentials on the affected device.
Affected Software
Event History
Frequently Asked Questions
What is CVE-2021-1130?
CVE-2021-1130 is a vulnerability in the web-based management interface of Cisco DNA Center software that allows an authenticated, remote attacker to conduct a cross-site scripting (XSS) attack.
What is the severity of CVE-2021-1130?
CVE-2021-1130 has a severity rating of medium, with a CVSS score of 4.8.
How does CVE-2021-1130 affect Cisco DNA Center software?
CVE-2021-1130 affects Cisco DNA Center software versions up to and including 2.2.1.0.
How can an attacker exploit CVE-2021-1130?
An authenticated, remote attacker can exploit CVE-2021-1130 to conduct a cross-site scripting (XSS) attack against a user of the Cisco DNA Center web-based management interface.
Is there a fix for CVE-2021-1130?
Yes, Cisco has released a security advisory providing details on how to mitigate the vulnerability. Please refer to the provided reference link for more information.